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Successful generation of virions from infected cells is a complex process
requiring orchestrated regulation of host and viral genes. Cells infected with
human cytomegalovirus (HCMV) undergo a dramatic reorganization of
membrane organelles resulting in the formation of the virion assembly com-
partment, a process that is not fully understood. Here we show that
acidification of vacuoles by the cellular v-ATPase is a crucial step in the for-
mation of the virion assembly compartment and disruption of acidification
results in mis-localization of virion components and a profound reduction in
infectious virus levels. In addition, knockdown of ATP6V0C blocks the
increase in nuclear size, normally associated with HCMV infection.
Inhibition of the v-ATPase does not affect intracellular levels of viral
DNA synthesis or gene expression, consistent with a defect in assembly
and egress. These studies identify a novel host factor involved in virion
production and a potential target for antiviral therapy.1. Introduction
Herpesvirus assembly is a complex process involving viral and host factors
[1,2]. In brief, viral DNA is synthesized in the nucleus and packaged into
nucleocapsids. These particles then escape the nuclear lamina and bud through
the inner nuclear membrane into the perinuclear space, acquiring a primary
envelope in the process. This viral envelope then fuses with the outer nuclear
membrane, allowing egress of the nucleocapsid into the cytoplasm. Once in
the cytoplasm, tegument proteins assemble on the capsid, and secondary envel-
opment occurs as the virion buds into the virion assembly compartment (VAC)
that is derived from the trans-Golgi network (TGN) and/or endoplasmic reticu-
lum (ER) membranes containing the viral glycoproteins. The mature virions are
then trafficked within these vesicles to the cell surface where they are released
into the extracellular space.
The human cytomegalovirus lytic replication cycle is long, releasing very
few particles until approximately 72 h post-infection (hpi), during which time
dramatic morphological changes occur in the cell to facilitate viral assembly.
Specifically, at these late times post-infection the cytoskeleton remodels [3],
the nucleus increases in volume and changes in morphology (taking on a
kidney shape) [4], and secretory vacuoles reorganize [3,5]. These secretory
vacuoles redistribute to form a juxtanuclear cytoplasmic inclusion called the
viral assembly compartment (VAC). This is the site where the majority of
viral tegument proteins and host cellular proteins [6] assemble on the surface
of the nucleocapsid before final envelopment occurs [3,7].
The HCMV VAC is derived from trans-Golgi network derived vacuoles,
early endosomes, and vacuoles bearing markers of the ESCRT III machinery
[3,5,8,9]. Despite re-localizing to form the VAC, markers for these compartments
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may perform different roles [9]. However, the specific mech-
anics of assembly within these compartments is not well
understood.
Until recently, the viral and host cellular factors that are
involved in the biogenesis of the VAC have been poorly
defined. Work by Das et al. using siRNAs against key HCMV
early-late and late viral genes has identified several viral pro-
teins that are required for the proper development of the VAC
(UL48, UL94 and UL103) [10]. Bughio et al. have established
that the UL133-138 locus is required for VAC formation
specifically in endothelial cells [11]. In addition to these
viral factors, several critical host genes have been identified
that are essential in VAC biogenesis [12]. More recently mul-
tiple HCMV miRNAs have been shown to be important for
VAC formation and virion production. The secretory path-
way genes VAMP3, RAB5C, RAB11A, SNAP23 and CDC42
have been identified as targets of HCMV encoded micro-
RNAs. Downregulation of these secretory pathway genes
by miR-UL112-1, US5-1 and US5-2 facilitates the formation
of the VAC [13]. Together, the current evidence indicates that
the biogenesis of the VAC is an elaborate process regulated
by the complex interplay of host cellular compartments,
their associated proteins and viral gene products.
Previously we identified ATP6V0C, the enzymatic com-
ponent of the vacuolar ATPase (v-ATPase) as an important
host factor for HCMV replication [14]. Here, we show that the
v-ATPase is required forcorrectVACformation, andknockdown
or inhibition of v-ATPase results in a profound and specific
assembly and egress phenotype during HCMV infection.2. Material and methods
2.1. Cells and viruses
Normal human dermal fibroblast (NHDF) cells (Clonetics)
were cultured in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum (FBS) and
penicillin-streptomycin-L-glutamine (PSG). HCMV strain
AD169 was obtained from the American Type Culture
Collection (Rockville, MD). TB40/E-GFP was obtained from
Dr Goodrum [15]. All HCMV strains were grown on primary
fibroblast cells following infection at low multiplicity of
infection (MOI). Virus stocks were isolated from cleared
supernatant over 10% sorbitol gradients as described
previously [16].
2.2. Small RNA transfections
Cells were transfected with small RNAs using RNAiMAX
lipofectamine reagent (Life Technologies) according to
manufacturer guidelines with the following modifications.
Fibroblast cells were double transfected with 20 pmol (40 nM
final concentration) of small RNA per 24 wells 8 h apart.
Control cells were transfected with a non-targeting negative
control siRNA (cat. 1027310, Life Technologies). ATP6V0C
(S80) and ATP6V1H (s28403) siRNA were purchased from
Life technologies. Confirmation of gene knockdown was
ascertained at an RNA level using qRT-PCR with specific
primer probe sets against ATP6V1H and ATP6V0C (Invitro-
gen). The efficacy of knockdown was in excess of 95% up
to 7 days post-transfection (data not shown). Cell viabilitywas established using CellTiter-Blue (Promega) according to
the manufacturer’s instruction.
2.3. Western blot analysis
Human primary fibroblast cells were grown in 10% FBS sup-
plemented DMEM before infection at a multiplicity of 3 with
AD169 or TB40/E-GFP. At 72 hpi, cells were harvested using
SDS sample loading buffer. 30 ml of protein sample were
loaded and proteins were probed using primary antibodies
to TGN46, (cat. PA5-23068, Pierce), EEA1 (cat. ab2900,
Abcam), pp28 (cat. CH19, Santa Cruz) and gB (cat. 2F12,
Abcam) according to the manufacturer’s guidelines. Protein
loading was normalized to GAPDH (Sigma). IR800 or
IR680 dye conjugated anti-rabbit IgG and anti-mouse IgG
secondary antibodies were purchased from LiCor. Blots
were imaged using infrared fluorescence of appropriately
tagged secondary antibodies and quantified using a LiCOR
Odyssey scanner and software.
2.4. Viral growth curve analysis
Viral growth curve analyses were performed as described in
[16]. NHDF cells were transfected as described above. At 72 h
post transfection with siRNAs, cells were infected at an MOI
of 1. At 24 hpi, cells were washed three times with PBS and
overlaid with fresh media. Infected cells were harvested,
scraped into media, at 24 hpi, and at every subsequent 24-h
time-point. Samples were snap frozen at 2808C to lyse the
cells. These lysates were then serially diluted, and used to
infect sub-confluent NHDFs. At 24 hpi, cells were overlaid
with 0.5% carboxymethyl-cellulose (CMC) diluted in
DMEM þ10% FBSþPSG. At 168 hpi, the CMC was removed,
monolayers were stained with toluidine blue and plaques
were counted.
2.5. Chloroquine treatment
NHDFs were seeded at 60–80% confluence in 24-well plates.
Twenty-four hours prior to infection, cells were overlaid with
DMEM þ10% FBS and PSG containing chloroquine to a final
concentration of 1.25, 2.5, 5, 10 and 25 mM. Cells were
infected with TB40/E-GFP at an MOI of 1. At 24 hpi, the
infectious inoculum was removed, and cells were washed
three times with PBS. Cells were then overlaid with media
containing chloroquine at the indicated concentrations. Cells
were harvested 7 days post-infection by scraping into the
media and frozen at 2808C. Virus levels were determined
by plaque assay as previously described. Cell viability was
established using CellTiter-Blue (Promega) according to the
manufacturer’s instruction.
2.6. RT-PCR analysis
Total RNAwas harvested using Trizol with concentrations and
RNA quality determined by nano-drop spectrophotometer
analysis. 100 ng of total RNA was DNAse treated (Promega)
then reverse transcribed using high capacity cDNA reverse
transcription kit (ABI). Real time PCR was performed using
gene specific primer probe sets from ABI on a Rotor gene
3000 (Corbet Research). Specific primer probe sequences were
kindly provided by Lauren Hook. IE86, UL83 and gH
primer and probes were synthesized by Life Technologies.
rsob.royalsocietypublishing.org
Open
Biol.7:160298
3
 on November 6, 2017http://rsob.royalsocietypublishing.org/Downloaded from The sequences for the primers for these assays are as follows:
gH (UL75); TTGCTAGCTCATCCGCACC (primer 1), AAG
AGACGCGTAAGGCGTTC (primer 2), CAGCGACCTGTA
CACACCCTGTTCCAGTAG (probe), HCMV IE86; ATGTCC
TGGCAGAACTCGGT (primer 1), GCTGCAAGAGTGGGTT
GTCA (primer 2), CCAGTAGCACCGGCCCCACG (probe),
HCMV UL83; TGGAGAACGTGTCGGTCAAC (primer 1),
GGATGTTCAGCATCTTGAGCG (primer 2), AGCCAGGA
GCCCATGTCGATCTATGTGTAC (probe). Relative expression
levels were determined by delta delta Ct calculation with levels
corrected to GAPDH levels.
2.7. Viral genome copy analysis
Infected cells were harvested at designated time-points and
applied to DNEasy blood and tissue kit columns (Qiagen).
DNA was extracted following the manufacturer’s protocol.
IE86, UL83 and gH primer and probes were synthesized by
Life Technologies. A primer probe set against gB was used to
quantitate viral DNA genome levels. For supernatant viral
genomes, virus was isolated by ultracentrifugation over a
sorbitol cushion as previously described [16]. The viral pellet
was resupended in DNase buffer and split into two aliquots,
one of which was treated for 1 h at 378C with Turbo DNase
(Ambion). DNA was then isolated by phenol chloroform
purification and PCR analysis performed as above.
2.8. Immunofluorescence and confocal microscopy
NHDF’s were seeded for siRNA transfection, and double-
transfected as previously described. At 72 h post-transfection,
cells were infected with AD169 at an MOI of 1. At 144 hpi,
coverslips were washed with PBS, and fixed for 15 min
with freshly prepared 4% paraformaldehyde in Dulbecco’s
PBS then permeabilised for 5 min (DPBSþ3% FBSþ0.2%
TX100. Coverslips were then blocked for 1 h at room temp-
erature (DPBSþ3% FBSþ0.5% Tween 20), before the
addition of primary antibodies to TGN46, (cat. PA5-23068,
Pierce), EEA1 (cat. ab2900, Abcam), pp28 (cat. CH19, Santa
Cruz), gB (cat. 2F12, Abcam) according to manufacturers
guidelines. Coverslips were incubated with primary anti-
bodies overnight at 48C. Coverslips were washed 3 times
with DPBSþ3% FBS before the addition of secondary
fluorescent antibodies (AlexaFluor anti-mouse 647 and anti-
rabbit 488, Life Technologies). Coverslips were incubated
for 1 h at room temperature, and washed three times with
DPBSþ3% FBS. Finally, coverslips were nuclear stained
using 1 : 1000 DAPI before mounting to slides using 5 ml
Prolong Gold anti-fade reagent (Life Technologies).
Images were acquired using a Zeiss LSM 710 confocal
microscope in accordance with the manufacturer’s instruc-
tions. Images were compiled and analysed using FIJI open
source image processing software [17]. Parallel images were
generated using human serum as a blocking agent to rule
out possible cross reactivity with the viral Fc receptor that has
been reported for some Rabbit polyclonal antibodies. Day
four time point samples and cells treated with chloroquine
were blocked with human serum (1%) prior to staining.
2.9. Electron microscopy
Fibroblast cells were cultured, transfected with siRNA,
and infected as specified above, and were fixed in 3%glutaraldehyde buffer at 120 hpi then washed in three 10 min
changes of 0.1 M sodium cacodylate. Specimens were then
post-fixed in 1% osmium tetroxide in 0.1 M sodium cacody-
late for 45 min, then washed in three 10 min changes of
0.1 M sodium cacodylate buffer. These samples were then
dehydrated in 50%, 70%, 90% and 100% ethanol (X3) for
15 min each, then in two 10min changes in propylene
oxide. Samples were then embedded in TAAB 812 resin.
Sections 1 mm thick were cut on a Leica Ultracut ultramicro-
tome, stained with Toluidine Blue, and viewed in a light
microscope to select suitable areas for investigation. Ultrathin
sections 60 nm thick were cut from selected areas, stained in
uranyl acetate and lead citrate, then viewed in a JEOL JEM-
1400 Plus TEM. Representative images were collected on a
GATAN OneView camera.
2.10. Data presentation
Data are presented throughout as a mean of multiple biologi-
cal replicates (N ¼ x), and error is displayed as the standard
deviation from the mean. Student t-test was used to determine
significance where indicated. For nuclear area analysis, a
two-way ANOVA test with replication was used.3. Results
3.1. Knockdown of ATP6V0C causes an assembly and
egress defect in HCMV infected cells
In a previous siRNA screening study we demonstrated that
knockdown of ATP6V0C prior to infectionwith GFP expressing
HCMV resulted in a modest reduction in reporter gene
expression compared with negative control transfected cells,
but a pronounced reduction in infectious virus production [14].
The differential effects on reporter gene expression and virus
production suggest a defect in virus assembly and egress. To
further investigate this phenomenon we measured the pro-
duction of infectious virus by plaque assays and compared this
to the levels of viral genome amplification in infected cells.
Production of infectious virus and viral genome copy number
was independently measured in cell lysates and virus from the
supernatant of infected cells, thereby independently measuring
intracellular versus secreted virus levels.
The titre of cell-associated virus from ATP6V0C siRNA
transfected fibroblasts was almost 2-log lower than that
observed in negative control cells 7 days post-infection
(figure 1a). However, in the supernatant virus from
ATP6V0C siRNA transfected cells, the titre was approxi-
mately 3-log lower than the negative control (figure 1a).
These data are consistent with previous results from plaque
assays on cell associated and supernatant virus combined,
which showed a 2–3-log decrease in viral titres [14]. How-
ever, the data shown in figure 1b demonstrate that there
was an approximately 80-fold reduction in virus titre in cell
associated virus and an approximately 700-fold reduction in
virus titre in supernatant in ATP6V0C siRNA transfected
fibroblast cells compared with the negative control cells, illus-
trating an order of magnitude difference when comparing
cell-associated with supernatant virus following ATP6V0C
knockdown. While infectious virus titres were substantially
reduced, viral genome levels were equivalent at 7 days
post-infection, suggesting the defect in virus production is
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Figure 1. Knockdown of ATP6V0C has greater effect on supernatant virus than cell associated virus. Fibroblast cells were transfected with siRNA against ATP6V0C or a
control siRNA and infected with TB40/E-GFP at an MOI of 1 and cells and supernatant collected 7 days post-infection. (a) Infectious cell associated and supernatant
virus levels were determined by dilution plaque assay following ATP6V0C knockdown. (b) Effects of ATP6V0C knockdown on infectious supernatant virus levels are
greater than effects on cell associated virus. (c) Cell associated viral genome levels were equivalent between control cells and ATP6V0C knockdown cells at 7 days
post-infection (d ) Supernatant virion genome levels were determined by qPCR. Supernatant was collected from cells 7 days post infection. Virions were isolated from
supernatant by ultracentrifugation then treated with DNase to degrade non-virion associated viral DNA. Primers against HCMV gB were used to determine viral
genome levels and primers to GAPDH (e) were used to confirm successful degradation of non-protected DNA (n ¼ 2).
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The reduction in infectious virus is not due to cytotoxic
effects as there was little difference in the viability of control
or ATP6V0C knockdown cells over the course of the 7-day
infection (electronic supplementary material, figure S1).
The dramatic loss in plaque forming units in the super-
natant could be due to a failure in production of cell free
infectious particles or a defect leading to the generation of
non-infectious particles. To investigate this, virion associated
genomes were measured in supernatant from infected control
or ATP6V0C knockdown cells. To differentiate between
virion genomes and free viral DNA released from lysed
cells, virions were isolated by ultracentrifugation then treated
with DNase. Virion-associated genomes would be protected
from DNase, whereas free viral DNA would be degraded.
While the majority of detectable viral DNA from control
cells was resistant to DNase treatment, indicating association
with virions, DNA detected from ATP6V0C knockdown cells
was sensitive to DNase treatment, suggesting that the
majority of viral DNA detected is not associated with virions
(figure 1d ). Cellular DNA, measured using GAPDH primers,
was not protected in supernatant from control or ATP6V0C
knockdown cells, confirming successful DNase treatment
(figure 1e). Higher levels of GAPDH DNA were detected in
the supernatant of infected cells compared with uninfected
cells, probably due to cytotoxic effects and cell death
caused by virus infection. Release of cellular DNA waslower in ATP6V0C knockdown cells, possibly reflecting
higher levels of cell viability at late time points (electronic
supplementary material, figure S1). This suggests a loss of
supernatant viral particles when ATP6V0C is knocked
down, although the production of non-infectious particles
that lack viral DNA, or unstable particles that lose structural
integrity once released from the cell cannot be ruled out.
To determine whether knockdown of ATP6V0C causes a
defect in viral gene expression, quantitative RT-PCR was per-
formed on RNA extracted from infected cells transfected with
ATP6V0C siRNA or a negative control siRNA. Relative tran-
script levels were determined for the immediate early
transcript IE86 and two late transcripts UL83 (pp65) and
UL75 (gH) (figure 2a–c). Knockdown of ATP6V0C did not
result in a significant reduction in the expression of viral tran-
scripts. However, an increase in viral transcription was
observed at early time points in ATP6V0C knockdown
cells. A corresponding increase in viral protein expression
at early times in cells knocked down for ATP6V0C was also
observed (figure 2d ). It is currently unclear why knockdown
of ATP6V0C results in increased viral gene expression at
early time points. However viral gene expression from
120 hpi is similar in control and knockdown cells, suggesting
that the defect in virus replication caused by knockdown of
ATP6V0C occurs down stream of viral entry, DNA amplifica-
tion and viral gene expression, consistent with a defect in
assembly and egress.
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capsids in the nucleus
To further define at which stage virus production is blocked
after ATP6V0C knockdown we analysed infected cells by
electron microscopy (EM). At 120 hpi, viral capsids can
clearly be observed within the nucleus of infected
ATP6V0C knockdown cells (figure 3a) and in control
siRNA transfected cells (figure 3b), suggesting no defect at
this stage of infection. Different stages of capsid formation
can also be discerned by EM analysis corresponding to
empty capsids, capsids containing scaffold proteins, and cap-
sids containing viral genomes (figure 3c) [12]. Manual
counting of 508 and 516 total individual capsids from nega-
tive control and ATP6V0C knockdown cells, respectively,
did not support statistically significant differences in the
numbers of each type of capsid between control cells and
ATP6V0C knockdown cells (figure 3d ). While EM analysis
can be a relatively insensitive method for characterizing
defects in virus replication due to sampling of thin subsec-
tions of the infected cell, these data suggest no gross defect
in virus capsid formation following ATP6V0C knockdown
and that the defect in virus production probably occurs
downstream of capsid assembly in the nucleus.3.3. ATP6V0C is required for HCMV virion assembly
compartment biogenesis
Following infection with HCMV, host-cellular endocytic and
exocytic membrane compartments undergo dramatic reor-
ganization, with the formation of the VAC late in infection
[3]. Given the role of the cellular v-ATPase in organelle acid-
ification and trafficking, we asked whether knockdown
of ATP6V0C could be disrupting viral driven membrane
reorganization and VAC formation.
In order to visualize the HCMV VAC, immunofluores-
cence microscopy was performed to observe the host
cellular markers, trans-Golgi network 46 (TGN46) and early
endosome antigen 1 (EEA1) with the virion structural protein
pp28. These are well-characterised markers of the HCMV
VAC. TGN46 is a type I integral membrane protein that loca-
lizes to the trans-Golgi network and is thought to play a role
in exocytic vesicle formation. EEA1 localizes to the early
endosomal sorting compartment involved in endocytosis. In
control cells, host cellular proteins TGN46 and EEA1 coloca-
lize with the viral tegument protein pp28 in a region adjacent
to an enlarged, kidney shape nucleus (figure 4). This staining
is diffuse, lacking any obvious boundaries or puncta, and is
consistent in localization and appearance with previous
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fected cells also showed the same defined colocalization of
cellular and viral markers (data not shown).
In cells transfected with siRNA against ATP6V0C, there
were several observable morphogenic differences to control
cells. The nuclei were smaller and the typical kidney shape
of an HCMV infected cell was not apparent (figure 4). The
host cellular markers of the VAC appear to localize to a similar
position within the cell, but staining of TGN46 is less diffuse
than that observed within a typical VAC, and the staining of
EEA1 has clear boundaries, indicative of a large vesicular
compartment. Most strikingly, pp28 does not colocalize with
the host cellular markers of the VAC (figure 4).
Images from a wider field of view demonstrate that this
defect is representative (figure 5a). Importantly, these quali-
tative observations are quantifiable. Scatter plots of pixel
intensity from a multi-cell field demonstrated that staining
for TGN46 and pp28 overlapped extensively in negative con-
trol cells, but did not for cells transfected with an siRNAagainst ATP6V0C (figure 5b). Colocalization analyses of
TGN46, EEA1 and pp28 were performed, with Pearson’s R
scores calculated (1 ¼ convergent 0 ¼ divergent). The fre-
quency of TGN46 and pp28 staining convergence was high
in negative control cells (R ¼ 0.58), and low in ATP6V0C
siRNA transfected cells (R ¼ 0.16). Similarly, EEA1 and
pp28 staining convergence was high in negative control
cells (R ¼ 0.41) and low in ATP6V0C siRNA transfected
cells (R ¼ 0.17) (figure 5c). Staining of earlier time points
(96 hpi) also showed distinct staining of TGN46 in
ATP6V0C knockdown cells, as did an additional cellular
marker associated with the VAC, GM130. In both cases a
loss of staining around the edge of central pp28 staining
was observed, indicating a defective organization of the
VAC (electronic supplementary material, figure S2a,b).
To examine whether the defect in VAC formation was due
to a possible gross disruption of the secretory apparatus as a
result of ATP6V0C knockdown, the distribution of TGN46
and EEA1 was analysed by immunofluorescence microscopy,
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blot analysis in uninfected cells. The distribution of both
TGN46 and EEA1 was similar in uninfected fibroblast cells
transfected with ATP6V0C siRNA when compared with a
negative control (figure 6a,b). While this does not rule out
defects in organelle function it does suggest that the orga-
nelles are structurally intact prior to infection. By 6 days
post-transfection some differences were detectable in the
staining pattern of the cellular marker GM130, perhaps
unsurprisingly showing some defects following long-term
knockdown of ATP6V0C (electronic supplementary material,
figure S3). The protein abundance of TGN46 and EEA1 were
similar in uninfected ATP6V0C siRNA and negative control
siRNA transfected fibroblast cells 48 h post-transfection and
infected cells, 72 hpi (figure 6c,d ).
3.4. Knockdown of ATP6V0C blocks HCMV associated
increase in nuclear area
In addition to major reorganizations of cellular membranes,
infection with HCMV causes a substantial increase in nuclear
size [4]. However, an increase in nuclear area fails to
occur following infection of fibroblast cells transfected with
ATP6V0C siRNA. Using FIJI imaging software, the nuclear
area of cells transfected with ATP6V0C siRNA were quanti-
fied, and shown to be smaller than those transfected with
negative control siRNA (figure 7a,b). The mean nuclear area
of cells transfected with ATP6V0C siRNA and infected withHCMV (AD169) was 55% smaller than negative control
siRNA transfected cells at 168 HPI (figure 7b). Previous
publications have observed a similar failure in nuclear enlar-
gement associated with loss in virion assembly compartment
formation and have suggested that the processes are inti-
mately involved [18–21]. This provides further evidence
that the cellular V-ATPase is required for the correct for-
mation of the human cytomegalovirus assembly and egress
cellular infrastructure.
3.5. v-ATPase acidification activity is required for
efficient virus production
The v-ATPase is a membrane-spanning, multi-domain ion
pump that is responsible for the regulation of pH in mem-
brane-bound organelles throughout the cell. These channels
consist of a luminal V1 domain, which is responsible for the
hydrolysis of ATP, and the trans-membrane VO domain,
which forms the proton channel. ATP6V0C is a critical com-
ponent of the VO domain [22]. The establishment of a low
intraluminal pH plays a crucial role within the endocytic
and secretory pathways. There have also been several obser-
vations in a variety of contexts that the VO domain of the
v-ATPase may have membrane fusion activity that is inde-
pendent of its role in the acidification of vacuoles. In mice,
C. elegans and Drosophila, the VO domain has been shown to
interact with VAMP-2, syntaxin-1 and Ca2þ release channels
to directly catalyse the mixing of two lipid bilayers [23–27].
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 on November 6, 2017http://rsob.royalsocietypublishing.org/Downloaded from To determine whether the assembly and egress phenotype
caused by ATP6V0C knockdown was due to a block in
vesicle acidification and disruption of the v-ATPase complex,
another critical component of the v-ATPase, ATP6V1H,
was knocked down using siRNA. ATP6V1H is the regula-
tory H subunit of the V1 domain of v-ATPase required
for metabolism of ATP by the v-ATPase complex and there-
fore necessary for function, but it is distinct from the VO
domain. Figure 8 demonstrates that siRNA knockdown of
ATP6V1H results in the same failure of VAC formation as
observed following ATP6V0C knockdown. Therefore, disrup-
tion of the ATPase, rather than an independent function of
ATP6V0C, appears to be responsible for the assembly and
egress phenotype.
To confirm that inhibition of infectious virus production
is due to a block in vacuolar acidification, virus replication
was measured following treatment of cells with chloroquine.
Chloroquine indirectly blocks the acidification of vacuoles.
It freely diffuses through cells, but upon reaching an acidic
compartment it undergoes a change of conformation that
renders it impermeable, causing it to accumulate in these com-
partments [28]. This acts to buffer any further change in pH in
these vacuoles. Fibroblast cells were incubated in media con-
taining chloroquine 24 h prior to and during infection with
the TB40/E-GFP strain of HCMV [15]. Inhibition of acidifica-
tion of vacuoles within the cell with chloroquine had a dosedependent inhibitory effect on the replication of TB40/E-GFP
(figure 9), and this was in the absence of any cytotoxic effects
(electronic supplementary material, figure S4). Similar to
ATP6V0C knockdown, viral transcription was relatively unaf-
fected by chloroquine treatment at 7 days post-infection
(figure 9b). Immunofluorescence staining of cells treated with
chloroquine also showed defective organization of the VAC
at 96 h post infection. Treatment with chloroquine resulted in
a loss of GM130 staining at the periphery of the VAC, with
GM130 staining showing a more compacted arrangement
(figure 9c). In addition the nuclei in chloroquine treated
infected cells are noticeably smaller (figure 9c).4. Discussion
Here, we show that knockdown of ATP6V0C results in a
profound assembly and egress phenotype that corresponds
to a failure in VAC formation. The failure in VAC formation
and virion production is due to a block in acidification of
vacuoles linked to the role of ATP6V0C in the v-ATPase com-
plex. While infectious supernatant virus was substantially
reduced, viral DNA amplification and gene expression were
not significantly impacted, consistent with an assembly and
egress phenotype. Nuclear capsid formation was also not dis-
rupted, suggesting a downstream block in virus production.
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reduced in the supernatant and there was a clear loss in cel-
lular membrane and nuclear reorganization required for the
formation of the virion assembly compartment.
The vATPases are multiprotein complexes that are
responsible for regulating vacuolar pH via the transport of
Hþ ions across membranes [22]. The establishment of pH
gradients between the cytosol and membrane bound orga-
nelles is fundamental to membrane trafficking pathways in
the cell. Acidification of early endosomes allows for the
release of ligand from internalized receptors, budding of mul-
tivesicular bodies is dependent on an acidic environment,
while lysosomal acidification is required for the activation
of degradative enzymes [29].
Within the context of VAC formation, the loss of function
phenotype that is observed when ATP6V0C is knocked down
is particularly intriguing. We observe that secretory and
endocytic markers that normally colocalize with the viral
assembly compartment fail to reorganize during infection
when ATP6V0C is knocked-down using siRNAs. It may be
that the failure of these compartments to reorganize results
in a failure in VAC formation or causes a critical and deleter-
ious change in VAC composition. We also observe that this
effect is dependent on infection, with secretory marker local-
ization and abundance not affected when ATP6V0C is
knocked down in uninfected cells.
Further characterization of the viral particles produced
may provide important clues as to the role of vacuolar acid-
ification in virion assembly and egress. If defects in
supernatant virions are subtle, for example, loss of specific
viral glycoproteins or tegument proteins, this may point to
a specific transport pathway associated with delivery of
viral proteins to the site of assembly. However if gross defects
are found, then failure of vacuole acidification may be linked
to a more general failure of virus assembly.We previously demonstrated that ATP6V0C is a target of
the HCMV miRNA miR-US25-1 [14]. Given the effect
ATP6V0C knockdown has on virus production this seems
counterintuitive. It is possible that targeting ATP6V0C
could be a mechanism of restricting virus production
during latent infection. However, regulation of ATP6V0C
by miR-US25-1 may not restrict virus production, as signifi-
cant inhibition of ATP6V0C levels would not occur until
late in infection, whereas the phenotype observed here
was caused by knockdown of ATP6V0C before virus infec-
tion. Knockdown by miR-US25-1 may also be less robust
compared with siRNA knockdown, resulting in different
phenotypic outcomes. Irrespective of the role of miR-US25-
1 targeting, ATP6V0C and the v-ATPase complex is clearly
an important host factor in the assembly and egress of
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